The digital content on TLO has been updated to align with the accessibility standards required by WCAG 2.1.
Amend HB 3026 (house committee report) on page 3, by striking lines 11 through 13 and substituting the following:
(b) In developing and implementing the program, the commission may not exclude from the program benefits prescription drugs used for the elective termination of a pregnancy if the drug is prescribed:
(1) for a purpose other than the elective termination of a pregnancy; or
(2) to terminate a pregnancy in accordance with an exception under Section 170A.002.